Core Insights - MiMedx Group, Inc. has launched AMNIOFIX Thyroid Shields, a product designed for use in endocrine surgery to protect the Recurrent Laryngeal Nerve and parathyroid glands during thyroidectomy procedures [1][2] Product Details - AMNIOFIX Thyroid Shields are allografts that provide a protective barrier post-thyroidectomy, supporting the healing process and preventing intraoperative modifications, thus saving time in the operating room [2] - The product is manufactured using the PURION process, is easy to apply, and has a shelf life of up to five years [2] Clinical Data - A retrospective study showed a 76% reduction in the incidence of Recurrent Laryngeal Nerve damage at 24 hours post-operation in patients who received AMNIOFIX compared to those who did not (3.4% vs. 14.4%, p<0.01) [3] Company Overview - MiMedx is a leader in providing healing solutions, focusing on chronic and hard-to-heal wounds, with a vision to be the global provider of innovative healing solutions [4]

Company Overview - MiMedx Group, Inc. is a pioneer in the healthcare sector, focusing on healing solutions for chronic and hard-to-heal wounds [3] - The company has over a decade of experience in providing products for wound care, burn, and surgical applications [3] - MiMedx aims to be the leading global provider of healing solutions through continuous innovation [3] Event Participation - MiMedx's senior management will participate in the BofA Securities 2025 Healthcare Conference in Las Vegas, NV [1] - The presentation is scheduled for May 13, 2025, at 5:15 p.m. PDT [2] - Investors interested in meeting with senior management can contact their Bank of America representative [2]

Company Announcement - MiMedx Group, Inc. will report its operating and financial results for Q1 2025 on April 30, 2025, after market close [1] - A webcast and conference call will be held at 4:30 p.m. Eastern Time on the same day to review the results [1] - The conference call can be accessed by U.S. investors at 877-407-6184 and international investors at 201-389-0877, with a conference ID of 13752696 [1] Company Overview - MiMedx is a pioneer and leader in healing solutions, focusing on chronic and hard-to-heal wounds [2] - The company aims to provide a leading portfolio of products for wound care, burn, and surgical sectors [2] - MiMedx's vision is to be the leading global provider of healing solutions through relentless innovation [2]